Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $4.45B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025